Journal of Clinical Endocrinology & Metabolism, Vol 55, 102-107, Copyright © 1982 by Endocrine Society

ARTICLES

Progesterone and adenosine 3',5'-monophosphate formation by isolated human corpora lutea of different ages: influences of human chorionic gonadotropin and prostaglandins

BL Dennefors, A Sjogren and L Hamberger

From each of 24 women undergoing minilaparotomy at various stages of the luteal phase of the cycle, the corpus luteum (CL) was excised in toto, decapsulated, cut into pieces, and incubated for short time periods (5--120 min). Incubations were carried out in the absence and presence of hCG, prostaglandin F2 alpha (PGF2 alpha) and PGE2, both alone and in combination. Dating of the CL was done meticulously using several parameters. After incubation, the tissue levels of cAMP and the media concentrations of progesterone (P) were determined. The basal P production in vitro was highest in CL of the midluteal phase. hCG stimulated cAMP formation in CL of all ages, with the highest levels of cAMP being produced in CL of the midluteal phase. PGE2 was found to increase cAMP formation and potentiate the hCG effect in young CL, but not in CL of the midluteal phase. PGF2 alpha, alone or in combination with hCG, had no effect on cAMP or P formation in either young or old CL, while in CL of the midluteal phase, PGF2 alpha significantly counteracted the stimulatory effect of hCG on both cAMP and P formation. These in vitro data show that PGF2 alpha is capable of inducing functional luteolysis in humans.

This article has been cited by other articles:

				A. Tropea, F. Tiberi, F. Minici, M. Orlando, M. F. Gangale, F. Romani, F. Miceli, S. Catino, S. Mancuso, M. Sanguinetti, et al. Ghrelin Affects the Release of Luteolytic and Luteotropic Factors in Human Luteal Cells J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3239 - 3245. [Abstract] [Full Text] [PDF]

				F. Miceli, A. Tropea, F. Minici, M. Orlando, G. Lamanna, M. F. Gangale, B. Panetta, F. Tiberi, S. Vaccari, R. Canipari, et al. Effects of Insulin-Like Growth Factor I and II on Prostaglandin Synthesis and Plasminogen Activator Activity in Human Umbilical Vein Endothelial Cells J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 372 - 378. [Abstract] [Full Text] [PDF]

				F. Miceli, A. Tropea, F. Minici, P. Navarra, A. Lanzone, and R. Apa Interleukin-1{beta} Stimulates Progesterone Production by in Vitro Human Luteal Cells: Evidence of a Mediatory Role of Prostaglandins J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2690 - 2694. [Abstract] [Full Text] [PDF]

				F. Miceli, F. Minici, M. G. Pardo, P. Navarra, C. Proto, S. Mancuso, A. Lanzone, and R. Apa Endothelins Enhance Prostaglandin (PGE2 and PGF2{{alpha}}) Biosynthesis and Release by Human Luteal Cells: Evidence of a New Paracrine/Autocrine Regulation of Luteal Function J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 811 - 817. [Abstract] [Full Text]

				B. E. Friden, E. Runesson, M. Hahlin, and M. Brannstrom Evidence for nitric oxide acting as a luteolytic factor in the human corpus luteum Mol. Hum. Reprod., May 1, 2000; 6(5): 397 - 403. [Abstract] [Full Text] [PDF]

				R. Apa, F. Miceli, E. Pierro, F. Minici, P. Navarra, A. Caruso, M. Napolitano, S. Mancuso, and A. Lanzone Paracrine Regulation of Insulin-Like Growth Factor I (IGF-I) and IGF-II on Prostaglandins F2{alpha} and E2 Synthesis by Human Corpus Luteum in Vitro: A Possible Balance of Luteotropic and Luteolytic Effects J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2507 - 2512. [Abstract] [Full Text]